☰

Christopher J. Yuskaitis, Ph.D. - Publications

Affiliations: 
2009 Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Yuskaitis CJ, Rossitto LA, Gurnani S, Bainbridge E, Poduri A, Sahin M. Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice. Human Molecular Genetics. PMID 31174205 DOI: 10.1093/Hmg/Ddz123  0.45
2019 Trowbridge SK, Yuskaitis CJ, Baumer N, Libenson M, Prabhu SP, Harini C. Brain MRI abnormalities in patients with infantile spasms and Down syndrome. Epilepsy & Behavior : E&B. 92: 57-60. PMID 30616066 DOI: 10.1016/J.Yebeh.2018.12.013  0.319
2017 Yuskaitis CJ, Jones BM, Wolfson RL, Super CE, Dhamne SC, Rotenberg A, Sabatini DM, Sahin M, Poduri A. A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility. Neurobiology of Disease. PMID 29274432 DOI: 10.1016/J.Nbd.2017.12.010  0.387
2015 Winden KD, Yuskaitis CJ, Poduri A. Megalencephaly and Macrocephaly. Seminars in Neurology. 35: 277-87. PMID 26060907 DOI: 10.1055/S-0035-1552622  0.331
2013 Poduri A, Heinzen EL, Chitsazzadeh V, Lasorsa FM, Elhosary PC, LaCoursiere CM, Martin E, Yuskaitis CJ, Hill RS, Atabay KD, Barry B, Partlow JN, Bashiri FA, Zeidan RM, Elmalik SA, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Annals of Neurology. 74: 873-82. PMID 24596948 DOI: 10.1002/Ana.23998  0.306
2010 Yuskaitis CJ, Beurel E, Jope RS. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochimica Et Biophysica Acta. 1802: 1006-12. PMID 20600866 DOI: 10.1016/J.Bbadis.2010.06.015  0.627
2010 Mines MA, Yuskaitis CJ, King MK, Beurel E, Jope RS. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Plos One. 5: e9706. PMID 20300527 DOI: 10.1371/Journal.Pone.0009706  0.639
2010 Yuskaitis CJ, Mines MA, King MK, Sweatt JD, Miller CA, Jope RS. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochemical Pharmacology. 79: 632-46. PMID 19799873 DOI: 10.1016/J.Bcp.2009.09.023  0.657
2009 Yuskaitis CJ, Jope RS. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cellular Signalling. 21: 264-73. PMID 19007880 DOI: 10.1016/J.Cellsig.2008.10.014  0.522
2009 Min WW, Yuskaitis CJ, Yan Q, Sikorski C, Chen S, Jope RS, Bauchwitz RP. Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology. 56: 463-72. PMID 18952114 DOI: 10.1016/J.Neuropharm.2008.09.017  0.613
2007 Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochemical Research. 32: 577-95. PMID 16944320 DOI: 10.1007/S11064-006-9128-5  0.515
Show low-probability matches.